Amicus Therapeutics, Inc (FOLD) insider trading
Every open-market stock purchase and sale by Amicus Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $5.4M over the last 12 months (11 sales). No open-market buys.
- Last insider buy: Burke W Whitman (Director), $15.7K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $5.4M (11 sales). Last close $14.49 on Apr 23, 2026.
Recent FOLD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Apr 27, 2026 | Bradley L Campbell (CEO) | Sold (not open market) | $14.6M |
| Apr 27, 2026 | Ellen Rosenberg (C-suite exec) | Sold (not open market) | $6.7M |
| Apr 27, 2026 | Jeff Castelli (C-suite exec) | Sold (not open market) | $6.2M |
| Apr 27, 2026 | Bradley L Campbell (CEO) | Sold (not open market) | $4.5M |
| Apr 27, 2026 | Bradley L Campbell (CEO) | Sold (not open market) | $3.8M |
| Apr 27, 2026 | Bradley L Campbell (CEO) | Sold (not open market) | $3.6M |
| Apr 27, 2026 | Bradley L Campbell (CEO) | Sold (not open market) | $3.4M |
| Apr 27, 2026 | David Michael Clark (C-suite exec) | Sold (not open market) | $3.2M |
| Apr 27, 2026 | Simon N.R. Harford (CFO) | Sold (not open market) | $2.4M |
| Apr 27, 2026 | Simon N.R. Harford (CFO) | Sold (not open market) | $2.1M |
| Apr 27, 2026 | Glenn Sblendorio (Insider) | Sold (not open market) | $2.1M |
| Apr 27, 2026 | Ellen Rosenberg (C-suite exec) | Sold (not open market) | $1.9M |
| Apr 27, 2026 | Samantha Prout (C-suite exec) | Sold (not open market) | $1.8M |
| Apr 27, 2026 | Bradley L Campbell (CEO) | Sold (not open market) | $1.8M |
| Apr 27, 2026 | Burke W Whitman (Insider) | Sold (not open market) | $1.7M |
| Apr 27, 2026 | Bradley L Campbell (CEO) | Sold (not open market) | $1.7M |
| Apr 27, 2026 | Michael Raab (Insider) | Sold (not open market) | $1.7M |
| Apr 27, 2026 | Lynn Dorsey Bleil (Insider) | Sold (not open market) | $1.7M |
| Apr 27, 2026 | Ellen Rosenberg (C-suite exec) | Sold (not open market) | $1.6M |
| Apr 27, 2026 | Ellen Rosenberg (C-suite exec) | Sold (not open market) | $1.6M |
| Apr 27, 2026 | Ellen Rosenberg (C-suite exec) | Sold (not open market) | $1.6M |
| Apr 27, 2026 | Bradley L Campbell (CEO) | Sold (not open market) | $1.5M |
| Apr 27, 2026 | Jeff Castelli (C-suite exec) | Sold (not open market) | $1.5M |
| Apr 27, 2026 | Jeff Castelli (C-suite exec) | Sold (not open market) | $1.4M |
| Apr 27, 2026 | Simon N.R. Harford (CFO) | Sold (not open market) | $1.4M |
Who's trading FOLD
- Burke W Whitman, Insider: other filings, last Apr 27, 2026
- Bradley L Campbell, CEO: sold $2.5M (5 sales), last Apr 27, 2026
- Jeff Castelli, C-suite exec: sold $774K (1 sale), last Apr 27, 2026
- David Michael Clark, C-suite exec: sold $1.1M (4 sales), last Apr 27, 2026
- Lynn Dorsey Bleil, Insider: other filings, last Apr 27, 2026
- Simon N.R. Harford, CFO: other filings, last Apr 27, 2026
- Michael Aaron Kelly, Insider: other filings, last Apr 27, 2026
- Margaret G McGlynn, Insider: other filings, last Apr 27, 2026
- Samantha Prout, C-suite exec: other filings, last Apr 27, 2026
- Michael Raab, Insider: other filings, last Apr 27, 2026
- Eiry Roberts, Insider: other filings, last Apr 27, 2026
- Ellen Rosenberg, C-suite exec: sold $958K (3 sales), last Apr 27, 2026
- Glenn Sblendorio, Insider: other filings, last Apr 27, 2026
- Craig A Wheeler, Insider: other filings, last Apr 27, 2026
Get free alerts when an insider at Amicus Therapeutics, Inc files a new trade →